Travere Therapeutics director proposes $500K share sale

The proposed transaction is tied to a Rule 10b5-1 plan adopted November 18, 2025; the notice also lists a prior sale in May.

Accepted by SEC EDGAR 06/12/2026 - 12:20 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Timothy Coughlin, a director of Travere Therapeutics, Inc. (TVTX), reported a proposed sale of 10,000 common shares with an aggregate market value of $500,429.72 and an approximate sale date of June 12, 2026. The proposed sale is under a Rule 10b5-1 plan adopted November 18, 2025. Coughlin also reported selling 3,250 common shares on May 15, 2026, for gross proceeds of $141,182.59.

Key Figures

Proposed shares to be sold: 10,000 shares Aggregate market value: $500,429.72 Approximate sale date: June 12, 2026 +3 more

6 metrics

Proposed shares to be sold 10,000 shares Common shares

Aggregate market value $500,429.72 Proposed sale

Approximate sale date June 12, 2026 Proposed sale

Prior shares sold 3,250 shares May 15, 2026

Gross proceeds $141,182.59 Sale on May 15, 2026

Shares outstanding 92,992,905 shares As reported for the securities information

Key Terms

Rule 10b5-1, Aggregate Market Value, Stock Options

3 terms

Rule 10b5-1 regulatory

"If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Stock Options financial

"Nature of Acquisition Transaction: Stock Options"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TVTX shares did director Timothy Coughlin propose to sell?

Timothy Coughlin reported a proposed sale of 10,000 common shares, with an aggregate market value of $500,429.72 and an approximate sale date of June 12, 2026.

How many TVTX shares did Timothy Coughlin sell in May 2026?

Coughlin reported selling 3,250 common shares on May 15, 2026, for gross proceeds of $141,182.59.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001376043
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Travere Therapeutics, Inc.
SEC File Number	001-36257
Address of Issuer	3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	Coughlin Timothy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Wells Fargo Clearing Services 1 N. Jefferson Ave St. Louis MO 63103	10000	500429.72	92992905	06/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2018	Stock Options	Issuer			10000	05/09/2018	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Timothy Coughlin 3611 Valley Centre DR Suite 300 San Diego CA 92130	Common Shares of TVTX	05/15/2026	3250	141182.59

144: Remarks and Signature

Remarks
Date of Notice	06/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Timothy Coughlin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)